Theories of Atherosclerosis
Several
theories advanced by eminent pathologists working in the field of
cardiovascular pathology have been proposed to explain the initiation and
growth of atherosclerotic plaques. As our knowledge increases it appears that these
theories are not mutually exclusive, and are indeed linked to each other.
Insudation
Theory: Proponents of this widely accepted theory proposed that the
critical events in atherosclerosis center on the focal accumulation of fat in
the vessel wall. It is believed that the lipid in these lesions is derived from
plasma lipoproteins, a view consistent with the role of blood lipids as risk
factors for myocardial infarction. Although there is still controversy over how
the lipid accumulates in the vessel wall, the hypothesis is widely accepted.
Whereas this hypothesis explains the source of plaque lipid, it does not
provide a complete explanation for the pathogenesis of the atherosclerotic
lesion. Since many other clinically important features of the plaque, such as
smooth muscle proliferation and thrombosis, remain unexplained, lipid
deposition appears to be necessary but not sufficient to explain plaque
development and growth.
Low-density
lipoprotein (LDL) is the form of lipid in the plasma that has been most closely
associated with accelerated atherosclerosis. The LDL particle is too large to
penetrate the tightly closed junctions between adjacent endothelial cell. However,
endothelial cells have receptors for both LDL and modified forms of LDL.
Transport can occur across an intact endothelium either by receptor-mediated
uptake of lipoproteins or by nonspecific uptake into micropinocytic channels.
Alternatively, lipid may be engulfed by monocytes in the blood and then
transported into the vascular wall inside these cells as they transmigrate into
the wall between dysfunctional endothelial cells. Lipid that becomes extracellular may be
trapped in the wall by altered components of the intimal matrix.
Encrustation
Theory: Initially supporters of
this theory asserted that material from the blood was deposited on the inner
surface of arteries and lead to thickening of the inner lining. Later it was thought to be the platelets and
fibrin of thrombi that initiated atherosclerosis. Mural thrombosis is not the initial event in
atherogenesis. However, mural thrombosis is a likely to promote the later
progression of the atherosclerotic lesion and is the major event leading to vascular
occlusion, especially in coronary arteries.
Inflammation and Repair; A Reaction
to Injury Theory: This theory was
originally proposed to explain the mechanisms that lead to the accumulation of
smooth muscle cells in atherosclerotic lesions. It was suggested that smooth
muscle cell proliferation depends on the release of polypeptide growth factors
by endothelial cells, macrophages, and smooth muscle cells themselves at sites
of injury. The nature of the injury is not well understood. This theory has been broadened to focus on
the role of all the cell types found in the artery wall in the initiation and
growth of an atherosclerotic lesion, including dysfunctional endothelial cells
and inflammatory cells; both macrophages and lymphocytes. It is suggested that
the cellular responses that occur during the pathogenesis of the lesion
constitute an inflammatory and a fibroproliferative response to injury. In this
theory, endothelial dysfunction compromises the integrity of the endothelial
barrier to macromolecules and leukocyte adhesion molecules on the surface
endothelial cells are activated to promote the infiltration of macrophages into
the subendothelium. The nature of the
injury is likely to involve numerous factors and is different in different people
depending on genetic and environmental conditions.
The
“reaction to injury” hypothesis evolved from the discovery that the growth of
smooth muscle cells in cell culture requires one or more platelet-derived
polypeptides. The best known of these is platelet-derived growth factor (PDGF),
which is also secreted by both macrophages and vascular wall cells. PDGF is not
only mitogenic for smooth muscle cells in vitro, but is also chemotactic for
them. Thus, in addition to stimulating the proliferation of cells already
located in the intima, PDGF may recruit smooth muscle cells from the media. The
number of growth promoters that can potentially induce proliferation of cells
include fibroblast growth factor (FGF), PDGF, transforming growth factor-b
(TGF-b), thrombin, LDL, endothelin, and others. There are also
growth inhibitors, such as heparin and nitric oxide (NO). Another suggestion was that smooth muscle
proliferation might be due to an aberration of growth control in one, or at
most a few cells, in a manner similar to the process in a benign smooth muscle
tumor. It has been established that some
plaques are monoclonal; that is, they originate from one or very few smooth
muscle cells. This suggests that some unknown factor, might induce fibrous cap
formation by altering growth control in the smooth muscle cells of the arterial
wall. Research has yet to identify possible mechanisms of monoclonality.
Post Comment
No comments